ArticleCancer cell2018

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer.

Gururaj Shivange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.